Anatara Lifesciences

Anatara Lifesciences Anatara is focused on developing its product pipeline for gastrointestinal health applications.

Anatara Lifesciences (ASX: ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need and a commitment to delivering real outcomes to patients and value to shareholders. Anatara Lifesciences (ASX: ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is sig

nificant unmet need. Anatara’s lead product, Detach, is a non-antibiotic approach to aid in the control of diarrhoeal disease (known as scour). Scour in piglets is an expensive, debilitating and in some cases, life-threatening condition. Anatara is evaluating commercialisation opportunities for Detach including options for launch in Australia, regulatory approval of this product in overseas markets, development of this product for species other than piglets and, global or regional licensing of Detach. Human Applications
Anatara’s "Gastrointestinal ReProgramming"​ GaRP product is a microbiome-targeted multi-component dietary supplement that has been designed to address the primary underlying factors associated with gastrointestinal disorders such as IBD and IBS. GaRP is a proprietary formulation which combines bromelain with other active ingredients and is designed to be used as an adjunct to prescription medication for IBD and IBS, empowering patients to better manage their chronic conditions. There is currently no dietary supplement that can effectively manage the most common symptoms of IBD and IBS. More than 11% of the global population are affected by IBS and there are more than 5 million IBD sufferers worldwide. Anatara is focused on delivering positive health outcomes for these sufferers, whilst driving value for shareholders by developing an effective and commercially attractive product in an area of critical need. Anatara’s team and opportunity
Backed by a well credentialed Board and Management team, and world-leading scientific collaborators, Anatara is uniquely positioned to fulfill a significant unmet medical need in gut health.

Anatara Lifesciences recently advised that eligibilty criteria has been expanded and the recruitment website would be up...
25/05/2022

Anatara Lifesciences recently advised that eligibilty criteria has been expanded and the recruitment website would be updated. This has now been completed.

📢 We are investigating a potential new treatment for IBS

IBS can be painful and debilitating. Some common symptoms include:

⚠️ Abdominal pain
⚠️ Gas and bloating
⚠️ Alternating constipation and diarrhoea

If you suffer from IBS, we are inviting you to take part in our latest medical study investigating a potential treatment!

👉 Express your interest here: https://trials.evrima.com.au/irritable-bowel-syndrome-ibs-medical-study-registration

May Newsletter including status update, information on the gut brain connection and Anatara's GaRP and 3FDC product and ...
17/05/2022

May Newsletter including status update, information on the gut brain connection and Anatara's GaRP and 3FDC product and clinical trial information. Also includes relevant news from across the globe.
Anatara e-news May 2022 -

CSIRO Adelaide is recruiting people to take part in a face to face clinical trial that is researching dietary supplement...
03/05/2022

CSIRO Adelaide is recruiting people to take part in a face to face clinical trial that is researching dietary supplementation and its effectiveness for changing how people feel

3FDC is made of three active ingredients. Although these ingredients have been used in people previously and are already known to have broad-ranging effects on our gut and body, the combined effect of these ingredients has not been studied yet. It’s believed the combined effect of these ingredients may include changing how people feel in a positive way through a link between the gut and the brain known as the gut-brain axis. This study will help us understand if consuming the 3FDC supplement will lead to improvements in how people with moderate depression, anxiety, or stress feel.

👉 Express your interest here: https://www.csiro.au/en/work-with-us/industries/health/Nutrition-and-health-research-clinic/Participate-in-a-study

The 🌎🌍🌏 needs to urgently increase investment in services for mental health to prevent a massive increase in mental health conditions.

CSIRO Adelaide is recruiting people to take part in a face to face clinical trial that is researching dietary supplement...
03/05/2022

CSIRO Adelaide is recruiting people to take part in a face to face clinical trial that is researching dietary supplementation and its effectiveness for changing how people feel

3FDC is made of three active ingredients. Although these ingredients have been used in people previously and are already known to have broad-ranging effects on our gut and body, the combined effect of these ingredients has not been studied yet. It’s believed the combined effect of these ingredients may include changing how people feel in a positive way through a link between the gut and the brain known as the gut-brain axis. This study will help us understand if consuming the 3FDC supplement will lead to improvements in how people with moderate depression, anxiety, or stress feel.

👉 Express your interest here: https://www.csiro.au/en/work-with-us/industries/health/Nutrition-and-health-research-clinic/Participate-in-a-study

Depression, anxiety, and panic disorders are common in those with IBS. We asked our patient advocates about their experiences managing these issues.

Please share this post. We have recently added an Adelaide site to sites recruiting for this study.ACT, Bruce - Paratus ...
23/02/2022

Please share this post. We have recently added an Adelaide site to sites recruiting for this study.

ACT, Bruce - Paratus Clinical Research Canberra
NSW, Blacktown - Paratus Clinical Research Western Sydney
NSW, Kanwal - Paratus Clinical Research Central Coast
SA, Adelaide - CSIRO Nutrition and Health Research Clinic
QLD, Albion - Paratus Clinical Research Brisbane

This site is not a part of the Facebook website or Facebook Inc.Additionally, This site is not endorsed by Facebook in any way.Facebook is a trademark of Facebook Inc.

Address

Suite 101, 55 Flemington Road
North Melbourne, VIC
3051

Alerts

Be the first to know and let us send you an email when Anatara Lifesciences posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Anatara Lifesciences:

Share